Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma
- PMID: 6893950
Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical